Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks.


Sumatriptan, a novel selective 5-hydroxytryptamine1d (5-HT1d) receptor agonist, which is highly effective in the acute treatment of migraine attacks, blocks dural neurogenic plasma extravasation and constricts cranial blood vessels in animal experiments. We measured intra- and extracranial blood flow velocities (BFV) with a transcranial Doppler device in 67… (More)


2 Figures and Tables

Slides referencing similar topics